Effects of augmentation of liver regeneration recombinant plasmid on rat hepatic fibrosis

Table 3 Serum content of HA, LN, PCIII and IV (mean±SD).

Group	n	HA (µg/L)	LN (µg/L)	PCIII (µg/L)	IV (µg/L)
N	10	338.67±48.24	33.71±14.53	10.17±2.78	36.80±15.04
M	9	435.91±40.31c	62.50±9.72c	18.13±7.11c	125.00±45.06d
Col	10	357.90±90.99a	40.98±13.74a	11.29±4.42a	37.78±8.89b
ALR1	9	327.43±111.26a	36.56±10.01a	12.60±8.80a	41.29±23.86b
ALR2	10	319.29±73.91a	36.04±8.89a	5.74±2.14aeg	38.38±16.36b

^aP<0.05 vs model control group;

^bP<0.01 vs model control group;

^cP<0.05 vs normal control group;

^dP<0.01 vs normal control group;

^eP<0.05 vs Col group;

^gP<0.05 vs ALR₁ group.